TIMP1 and breast carcinoma: Consistent to our results on the protease activities, Wu et al. found that serum levels of MMP-9 and TIMP-1 were significantly higher in breast cancer patients than in benign breast disease and healthy controls, and that they associated with tumor progression [31].